## Abstract The composition of tumor infiltrating lymphocytes (TIL) is heterogeneous. In addition, the ratio of various subpopulations in the tumor microenvironment is highly dependent on the nature of the host's immune response. Here, we characterize Foxp3‐expressing CD8^+^ T cells in the tumor th
In vivo depletion of DC impairs the anti-tumor effect of agonistic anti-CD137 mAb
✍ Scribed by Oihana Murillo; Juan Dubrot; Asís Palazón; Ainhoa Arina; Arantza Azpilikueta; Carlos Alfaro; Sarai Solano; María C. Ochoa; Carmen Berasain; Izaskun Gabari; José. L. Pérez-Gracia; Pedro Berraondo; Sandra Hervás-Stubbs; Ignacio Melero
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 532 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The anti-tumor effects of actinomycin D (Act D) and recombinant human tumor necrosis factor (TNF)-a have been studied on 4 established murine tumor cell lines: MmBI6 melanoma, Lewis lung (LL/2) carcinoma, L I sarcoma and L I 2 10 leukemia. During short-term incubation (24 hr) Act D produced dosedepe
The present study demonstrates that the transfection of B7-I or its variant MB7-2 genes into MHC class I+ tumor cells (B 16-BL6 or K I 735-M2 melanoma) resulted in the remarkable reduction of lung metastasis caused by i.v. injection into immunocompetent syngeneic mice. However, i.v. injection of the
## Abstract Target‐specific acute myeloid leukemia (AML) immunotherapy requires selective cell‐surface antigens on AML blast cells. CD64 is a promising candidate antigen because it is abundantly expressed on monocytoid differentiated AML subtypes. In previous studies, a chemically linked full‐lengt